Analyte Health and Teladoc Announce Partnership

Solution integrates lab testing to improve the overall telehealth experience for patients and physicians

Analyte Health, Inc., an integrated health care partner that connects patients and telehealth providers with laboratory testing services and Teladoc, Inc. (NYSE: TDOC), the undisputed leader in telehealth, announced a partnership that delivers lab diagnostics services through the Teladoc telehealth platform.

“The evolution of telehealth has changed the way we receive and deliver care. Our integrated solution enhances diagnostic capabilities for physicians while meeting patients’ growing demands for private and convenient health care,” said Dr. Frank Cockerill, CEO, Analyte Health. “Teladoc’s leadership in the telehealth industry has transformed the approach to care and we are excited to assist them in expanding their services. The partnership between Analyte Health and Teladoc bridges the gap between lab testing and telehealth, and together, we are reinventing the health care experience for patients and physicians.”

“The partnership with Analyte further supports our goal to expand access to quality, affordable care through continued innovation of the Teladoc telehealth platform,” said Jason Gorevic, CEO, Teladoc. “No one else is able to rival this breadth of comprehensive lab services. This new dimension enables us to bring the lab to patients during their telemedicine visits to further support quality outcomes.”

Analyte Health provides a comprehensive suite of services, including managing logistics like technological infrastructure, billing and customer support. The process also makes it easier for both physicians and patients. Now, with the click of a button, physicians in the Teladoc network can order the lab tests they need to confirm diagnoses, for conditions in the areas of acute and chronic care, behavioral health, and preventive health. Teladoc members will be directed to a convenient specimen collection location and lab results are available within three days for the physician and patient to discuss appropriate treatment and next steps. In future phases, these services will be available in same-day, on-demand mobile experiences. The solution opens doors to reach more patients and provide them with secure, private, and effective care anytime, anywhere.

About Analyte Health

Analyte Health is an integrated healthcare partner that connects patients and telehealth providers with laboratory testing services. Analyte Health's configurable platform allows telehealth providers to seamlessly incorporate lab testing for acute illness, chronic disease and preventive and behavioral health into the virtual doctor-patient relationship – increasing the quality and accuracy of diagnoses and treatment plans. We focus on creating an outstanding patient experience by making lab testing more convenient, accessible, and faster than traditional brick and mortar office visits. On average, we reduce the office visit and lab testing turnaround time from weeks to three days or less. Analyte Health has consistently achieved a Net Promoter Score of 70 or higher. To learn more, please visit www.analytehealth.com.

About Teladoc

Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of telehealth services and a pioneering force in bringing the virtual care visit into the mainstream of today’s health care ecosystem. Serving some 7,000 clients — including health plans, health systems, employers and other organizations — more than 17 million members can use phone, mobile devices and secure online video to connect within minutes to Teladoc’s network of more than 3,100 board-certified, state-licensed physicians and behavioral health specialists, 24/7. With national coverage, a robust, scalable platform and a Lewisville, TX-based member services center staffed by 400 employees, Teladoc offers the industry’s most comprehensive and complete telehealth solution including primary care, behavioral health care, dermatology, tobacco cessation and more. For additional information, please visit www.teladoc.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170109006115/en/

Edelman, for Analyte HealthRebecca Greenwood, 407-377-6871rebecca.greenwood@edelman.comorTeladocCourtney McLeod, 914-265-6789Director of Public Relationscmcleod@teladoc.com

Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Mar 2024 to Apr 2024